Inflammatory bowel disease (IBD) has a peak age of diagnosis before the age of 35 years.
Concerns about infertility, adverse pregnancy outcomes, and heritability of IBD have …

Background Pregnancies in women with chronic disease are on the rise. This pertains to
autoimmune diseases in particular since these tend to affect women of childbearing age …

2. Methods This document represents the third version of the European Consensus on
reproduction in IBD. The development of this Consensus included the formulation of …

Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …

Abstract Background and Aims Filgotinib is a small molecule that selectively inhibits Janus
kinase [JAK] type 1. It is already approved for the treatment of rheumatoid arthritis and is …

Summary Background and Aims Inflammatory bowel disease (IBD) activity during pregnancy
is associated with adverse pregnancy outcomes. We aimed to identify key clinical …

Objective Active inflammatory bowel disease (IBD) during pregnancy may require the use of
corticosteroids. The aim of this study was to investigate the impact of in utero corticosteroid …

Background: Continuation of biologics for inflammatory disorders during pregnancy is still a
difficult decision. Many women with inflammatory bowel diseases (IBDs) stop anti–tumor …

Background People with inflammatory or autoimmune diseases are recommended to
continue immunomodulatory biologic agents throughout pregnancy. However, concerns …

Anti-TNF therapy has been successfully used as first-line biologic treatment for moderate-to-
severe inflammatory bowel disease (IBD), in both 'step-up'and 'top-down'approaches, and …